PF-4800567 [Ligand Id: 8050] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL2069623
  • casein kinase 1 alpha 1/Casein kinase I isoform alpha in Human [ChEMBL: CHEMBL2793] [GtoPdb: 1995] [UniProtKB: P48729]
There should be some charts here, you may need to enable JavaScript!
  • casein kinase 1 delta/Casein kinase I isoform delta in Human [ChEMBL: CHEMBL2828] [GtoPdb: 1997] [UniProtKB: P48730]
There should be some charts here, you may need to enable JavaScript!
  • casein kinase 1 epsilon/Casein kinase I isoform epsilon in Human [ChEMBL: CHEMBL4937] [GtoPdb: 1998] [UniProtKB: P49674]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
casein kinase 1 alpha 1/Casein kinase I isoform alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2793] [GtoPdb: 1995] [UniProtKB: P48729]
ChEMBL Identification of CSNK1A1 Inhibitors: In order to identify inhibitors of CSNK1A1, the CSNK1A1 knockdown signatures in CMap were compared to all CMap compound signatures, and resultant compounds were ranked by strength of signature similarity. The top ranked compound from this analysis (compound 1) was predicted to act as a CSNK1A1 inhibitor.The CMap prediction was confirmed using Kinomescan (FIG. 1 ). Compound 1 bound to only six out of over 400 kinases tested in the assay, including CSNK1A1. B 6.07 pIC50 857 nM IC50 US-11633415-B2. Compounds and methods useful for treating or preventing cancers (2023)
casein kinase 1 delta/Casein kinase I isoform delta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2828] [GtoPdb: 1997] [UniProtKB: P48730]
ChEMBL Inhibition of CK1delta B 6.15 pIC50 711 nM IC50 Eur J Med Chem (2012) 56: 30-38 [PMID:22944772]
ChEMBL Inhibition of Casein kinase 1 delta B 6.15 pIC50 711 nM IC50 J Med Chem (2012) 55: 10307-10311 [PMID:23106386]
ChEMBL Inhibition of human CK1delta in presence of [gamma33P]-ATP B 6.15 pIC50 711 nM IC50 Eur J Med Chem (2019) 181: 111581-111581 [PMID:31400711]
ChEMBL Inhibition of CK1delta (unknown origin) B 6.15 pIC50 711 nM IC50 J Med Chem (2023) 66: 7162-7178 [PMID:37204207]
GtoPdb - - 6.15 pIC50 711 nM IC50 J Pharmacol Exp Ther (2009) 330: 430-9 [PMID:19458106]
ChEMBL Inhibition of human full length CK1delta1 (2 to 415 residues) using PLSRTLpSVASLPGL as substrate after 2 hrs by kinase-glo assay B 7.49 pIC50 32 nM IC50 Nat Rev Drug Discov (2017) 16: 424-440 [PMID:28280261]
casein kinase 1 epsilon/Casein kinase I isoform epsilon in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4937] [GtoPdb: 1998] [UniProtKB: P49674]
GtoPdb - - 7.49 pIC50 32 nM IC50 J Pharmacol Exp Ther (2009) 330: 430-9 [PMID:19458106]
ChEMBL Inhibition of CK1epsilon B 7.49 pIC50 32 nM IC50 Eur J Med Chem (2012) 56: 30-38 [PMID:22944772]
ChEMBL Inhibition of Casein kinase 1 epsilon B 7.49 pIC50 32 nM IC50 J Med Chem (2012) 55: 10307-10311 [PMID:23106386]
ChEMBL Inhibition of human full length polyhistidine-tagged CK1epsilon expressed in Escherichia coli BL21-Codon-Plus (DE3)-RIL using PLSRTLpSVASLPGL as substrate after 2 hrs by kinase-glo assay B 7.49 pIC50 32 nM IC50 Nat Rev Drug Discov (2017) 16: 424-440 [PMID:28280261]
ChEMBL Inhibition of human CK1epsilon in presence of [gamma33P]-ATP B 7.49 pIC50 32 nM IC50 Eur J Med Chem (2019) 181: 111581-111581 [PMID:31400711]
ChEMBL Inhibition of CK1epsilon (unknown origin) B 7.49 pIC50 32 nM IC50 J Med Chem (2023) 66: 7162-7178 [PMID:37204207]
ChEMBL Inhibition of recombinant human full-length N-terminal GST-tagged CK1epsilon expressed in baculovirus infected Sf9 insect cells using casein as substrate measured after 60 mins by ADP-glo kinase assay B 8.13 pEC50 7.4 nM EC50 Blood (2017) 129: 88-99 [PMID:27784673]

ChEMBL data shown on this page come from version 36:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]